# Health R&D Services; Health Care Services; Applied Research (PSC AN12) Canonical: https://abierto.us/psc/an12 Federal contract opportunities under product and service code AN12. 34 opportunities in the window, 5 open now. ## Open now (5) - NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM (75N98026R00109), National Institutes of Health, due September 21, 2026 at 5:00 PM EDT. https://abierto.us/opportunities/75n98026r00109 - Whole-person Assessment of Response and Risk after transformative therapies: In (75N98026R00146), National Institutes of Health, due October 2, 2026 at 3:00 PM EDT. https://abierto.us/opportunities/75n98026r00146 - CureSCi Long-Term Follow-Up (LTFU) Consortium: Coordinating Center Activities, (75N98026R00150), National Institutes of Health, due October 2, 2026 at 3:00 PM EDT. https://abierto.us/opportunities/75n98026r00150 - Risk Underlying Rural Areas Longitudinal (RURAL) H (75N98026R00074), National Institutes of Health, due November 5, 2026 at 3:00 PM EST. https://abierto.us/opportunities/75n98026r00074 - Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response (75A50126R00001_RFP_NPIVS_27), Office of Assistant Secretary for Preparedness and Response, due November 20, 2026 at 5:00 PM EST. https://abierto.us/opportunities/75a50126r00001rfpnpivs27 ## Recent (29 in all) - September 15, 2026: Machine Learning Analytics for Total Brain Diagnostics Project (36C24E26P0037), justification, awarded to Oregon Health & Science University Portland 97239. https://abierto.us/opportunities/36c24e26p0037 - September 13, 2026: The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension (75N98026R00085), special notice. https://abierto.us/opportunities/75n98026r00085 - September 9, 2026: National NeuroHIV Tissue Consortium (NNTC) - Clinical Sites (75N98026R00139), justification, awarded to Washington University, the. https://abierto.us/opportunities/75n98026r00139 - August 26, 2026: Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance Use-Induced Respiratory Depression — In Vivo Validation (75F40126Q00382), presolicitation. https://abierto.us/opportunities/75f40126q00382 - August 21, 2026: Research support for the Division of Population Health and Data Science at the Massachusetts Veterans Epidemiology Research and Informatics Center (MAVERIC) in the Boston VA Healthcare System. (36C24E26N0236), award notice, awarded to President and Fellows of Harvard College. https://abierto.us/opportunities/36c24e26n0236 - August 20, 2026: MRI Scans for VA Approved Research (36C26126Q1179), special notice, awarded to The Leland Stanford Junior University. https://abierto.us/opportunities/36c26126q1179 - August 17, 2026: Flexible wheelchair cushion pressure sensor mat (36C24426Q0849), sources sought. https://abierto.us/opportunities/36c24426q0849 - August 17, 2026: Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances (75N95024R00094), award notice, awarded to TCG GREENCHEM Inc. Ewing. https://abierto.us/opportunities/75n95024r00094 - August 11, 2026: Web-Based Training Development for Ralph H Johnson VA Medical Center (36C24726Q0826), combined synopsis and solicitation. https://abierto.us/opportunities/36c24726q0826 - August 11, 2026: Machine Learning Analytics for Total Brain Diagnostics Project (36C24E26Q0093), special notice. https://abierto.us/opportunities/36c24e26q0093 - August 10, 2026: Postmortem Tissue Samples (36C24126Q0727), special notice. https://abierto.us/opportunities/36c24126q0727 - August 4, 2026: Evaluation of a Lead NNMT Inhibitor in Humanized M (75N98026Q00941), solicitation. https://abierto.us/opportunities/75n98026q00941 - August 3, 2026: 2026 NIAID DMID Omnibus Broad Agency Announcement (HHS-NIH-NIAID-BAA2025-1), award notice, awarded to Zepto Life Technology, Inc.. https://abierto.us/opportunities/hhsnihniaidbaa20251 - July 31, 2026: Best Pharmaceuticals for Children Act DCC (75N94026R00008), presolicitation. https://abierto.us/opportunities/75n94026r00008 - July 30, 2026: Presolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response (75A50126R00001_RFP_PreSolNotice_NPIVS-2027), presolicitation. https://abierto.us/opportunities/75a50126r00001rfppresolnoticenpivs2027 - July 29, 2026: BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1 (HT9425-23-S-SOC1-0003), special notice. https://abierto.us/opportunities/ht942523ssoc10003 - July 27, 2026: Research service necessary to execute a NAMRU SOUTH Zika study in Panama. (ERP_PR_1301393620), solicitation. https://abierto.us/opportunities/erppr1301393620 - July 27, 2026: Justification for sole source acquisition - RISE Laboratory equipment (HS002126QE054), justification. https://abierto.us/opportunities/hs002126qe054 - July 24, 2026: Study entitled “Chagas disease and leishmaniasis surveillance in Antioquia”. (ERP_13013778730), solicitation. https://abierto.us/opportunities/erp13013778730 - July 22, 2026: TECHNOLOGY LICENSING OPPORTUNITY: Acid-tuned Terphenyl Membranes (ATM) (S-195397), special notice. https://abierto.us/opportunities/s195397 - July 22, 2026: TECHNOLOGY LICENSING OPPORTUNITY: ScreenFlow Liquid-Liquid Microcontactor (S-195418), special notice. https://abierto.us/opportunities/s195418 - July 21, 2026: Immune Mechanisms of Protection Against Mycobacterium tuberculosis Center (IMPAc-TB) (BAA-75N93026R00008), solicitation. https://abierto.us/opportunities/baa75n93026r00008 - July 17, 2026: Web-Based Training Development for Ralph H Johnson VAMC (36C24726Q0690_1), combined synopsis and solicitation. https://abierto.us/opportunities/36c24726q06901 - July 17, 2026: RADIOLOGICAL OR NUCLEAR MEDICAL COUNTERMEASURE PRODUCT DEVELOPMENT SUPPORT (PDS) (75N93026R00005), solicitation. https://abierto.us/opportunities/75n93026r00005 - July 15, 2026: Notice of Intent to Sole Source - Development and Validation of Diagnostic Methods for Coccidioidomycosis (Valley Fever) (Notice_of_Intent_to_Sole_Source_Development_and_Validation_of_Diagnostic_Methods_for_Coccidioidomycosis_(Valley_Fever)), special notice. https://abierto.us/opportunities/noticeofintenttosolesourcedevelopmentandvalidationofdiagnosticmethodsforcoccidioidomycosisvalleyfever - July 14, 2026: 534-26-4-6727-0013 / BIOMEDICAL INFORMATICS CENTER (BMIC) - NEW BASE plus ONE / (VA-26-00063517) (36C24726Q0690), combined synopsis and solicitation. https://abierto.us/opportunities/36c24726q0690 - July 8, 2026: National Cancer Institute (NCI) Small Business Innovation Research (SBIR) Innovative Concept Award Program – Fiscal Year 2027 (75N91026R00109), presolicitation. https://abierto.us/opportunities/75n91026r00109 - July 8, 2026: Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products (75N95025R00005), award notice, awarded to EMINENT SERVICES Corp. Frederick. https://abierto.us/opportunities/75n95025r00005 - July 1, 2026: Strong Heart Study (SHS) – Coordinating Center (CC) (75N98026R00115), special notice. https://abierto.us/opportunities/75n98026r00115 --- Sources: SAM.gov Contract Opportunities extract and USAspending.gov award data. Cite https://abierto.us/psc/an12.